Tag: Kiran Shaw
Biocon revenue up 59% at Rs 3,929 crore in Q4FY23
The company's revenue in biosimilars is up 114%; research services up 31% and EBITDA at Rs 1,152 crore up 75%
ABLE’s 20th Anniversary: Realistic policies & regulations critical for bioeconomy to...
Kiran was speaking at the 20th Anniversary Celebration of the Association of Biotechnology Led Enterprises (ABLE) on April 07, 2023. The theme of the event was "India-A Resilient Global Biotech Destination."
Riding on biologics wave, Biocon registers two fold growth during FY...
For the fiscal year ended March 2019, the Biocon's net profit rose over two-fold to Rs 905.3 crore as against Rs 372.4 crore for 2017-18. Company registered 64% growth in Q4 of FY19, earning 214 cr in net profits.................
BioVoice eMag March 2017 Issue-10 Volume-1
BioVoice eMag March 2017 Issue-10 Volume-1:
This edition of BioVoice in its detailed cover story highlights the gains and pains of the budget 2017. The...
Biocon’s net profit jumps to Rs 146.7 cr in 2nd quarter...
With consolidated net profit of Rs 146.7 crore, the biotechnology giant, Biocon has shown good performance for the second quarter of financial year 2016-17....